Abstract: Methods and devices to compensate for individual hearing loss when listening to audio systems are described. An individualized frequency configuration is applied to the output of an audio system wherein the volume of audio signals at one or more frequencies is adjusted to compensate for a user's hearing deficit. The devices are operable to work with multiple users.

Abstract: Methods and devices to compensate for individual hearing loss when listening to audio systems are described. An individualized frequency configuration is applied to the output of an audio system wherein the volume of audio signals at one or more frequencies is adjusted to compensate for a user's hearing deficit. The devices are operable to work with multiple users.

Abstract: The method of this invention is directed to a treatment of hypersomnia or insomnia that is secondary to another condition in men and women by administering to a patient a therapeutically effective amount of chromium in a pharmaceutically acceptable form, for instance in conjunction with the administration of another composition to treat the other condition, such as a standard antidepressant composition, such as a selective serotonin reuptake inhibitor composition. Chromium is administered to the patient at dosages in a preferred range of about 200 to about 500 micrograms chromium.

Abstract: The method of this invention is directed to a treatment of alcohol craving in men and women and to a treatment of pre-menstrual syndrome (PMS) in women by administering to a patient a therapeutically effective amount of chromium in a pharmaceutically acceptable form either alone or in conjunction with the administration of a standard antidepressant composition, such as a selective serotonin reuptake inhibitor composition. Chromium is administered to the patient at dosages in a preferred range of about 200 to about 500 micrograms chromium.

Abstract: A method of facilitating diagnosis of a psychiatric disorder in a patient is disclosed. The method includes the steps of providing the patient with one or more questions relating to symptoms of one or more psychiatric disorders in a format which facilitates recording the patient's answers to the one or more questions; and establishing a preliminary disorder indication based on the answers provided by the patient to the one or more questions. The diagnosis of a psychiatric disorder in the patient is thus facilitated by the format which facilitates recording the patient's answers to the one or more questions and by the establishing a preliminary disorder indication.

Abstract: The method of this invention is directed to a treatment of depression in men and women by administering to a patient a therapeutically effective amount of chromium in a pharmaceutically acceptable form. Chromium, preferably in the form of chromium picolinate, is administered to the patient at dosages in a preferred range of about 200 to about 500 micrograms chromium.

Abstract: The method of this invention is directed to a treatment of depression in men and women and to a treatment of pre-menstrual syndrome (PMS) in women by administering to a patient a therapeutically effective amount of chromium in a pharmaceutically acceptable form either alone or in conjunction with the administration of a standard antidepressant composition, such as a selective serotonin reuptake inhibitor composition. Chromium, preferably in the form of chromium picolinate, is administered to the patient at dosages in a preferred range of about 200 to about 500 micrograms chromium.

Abstract: The method of this invention is directed to a treatment of depression in men and women and to a treatment of pre-menstrual syndrome (PMS) in women by administering to a patient a therapeutically effective amount of chromium in a pharmaceutically acceptable form either alone or in conjunction with the administration of a standard antidepressant composition, such as a selective serotonin reuptake inhibitor composition. Chromium, preferably in the form of chromium picolinate, is administered to the patient at dosages in a preferred range of about 200 to about 500 micrograms chromium.

Abstract: The method of this invention is directed to a treatment of depression in men and women and to a treatment of pre-menstrual syndrome (PMS) in women by administering to a patient a therapeutically effective amount of chromium in a pharmaceutically acceptable form either alone or in conjunction with the administration of a standard antidepressant composition, such as a selective serotonin reuptake inhibitor composition. Chromium, preferably in the form of chromium picolinate, is administered to the patient at dosages in a preferred range of about 200 to about 500 micrograms chromium.